medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 6

<< Back Next >>

Rev Invest Clin 2017; 69 (6)

Dose Volume Effect of Acute Diarrhea in Post-Operative Radiation for Gynecologic Cancer

Li Q, Chen J, Zhu B, Jiang M, Liu W, Lu E, Liu Qiao-ling

Language: Spanish
References: 19
Page: 329-335
PDF size: 74.93 Kb.


ABSTRACT

Background: Diarrhea is the primary symptom of concern in acute post-operative radiation-induced enteritis in gynecologic cancer. We retrospectively studied the correlation between the volume of irradiated small bowel and the development of acute diarrhea in these patients . Materials and Methods: A total of 100 post-operative gynecologic cancer patients were analyzed. Pelvic computed tomography was performed to calculate the volume of irradiated small bowel. A dose-volume histogram was calculated from 5 to 40 Gy at 5 Gy intervals. Patients receiving conventional whole pelvic radiation therapy (RT) were assigned to Group I, and those who received intensity-modulated RT (IMRT) were assigned to Group II. A total dose of 40-50 Gy was delivered at 1.8-2.0 Gy per fraction daily. Acute diarrhea during treatment was scored. All data were expressed as a mean ± standard deviation. Different dose-volume parameters for small bowel in Grades 0-1 and Grades 2-3 diarrhea were calculated by the independent t-test. Univariate analysis of diarrhea risk factors was performed with the independent t-test or Chi-square/Fisher exact test. Results: Of the 77 patients who received conventional RT, 44 (57.14%) experienced Grades 2-3 toxicities. Of the 23 patients who received IMRT, 9 (39.13%) experienced Grades 2-3 toxicities. Concurrent chemotherapy was slightly associated with a higher damage score in both groups (p = 0.028). None of the patient factors (weight, percentage depth dosage, dose fraction, distance from skin to tumor, lymph node metastasis, chemotherapy, block, brachytherapy, hypertension, or diabetes) were correlated with diarrhea in the two groups. The volumes of irradiated small bowel in patients who experienced Grades 2-3 diarrhea were significantly larger than those in patients who experienced Grades 0-1 diarrhea at all dose levels in Group I. V20 (372.19 ± 133.26 cm3, p = 0.004) was an independent factor for developing Grades 2-3 diarrhea in Group I. V25 (290.35 ± 130.22 cm3, p = 0.001) was an independent risk factor for all patients who developed higher score diarrhea. Conclusions: The volume of irradiated small bowel was an independent risk factor for all patients who developed diarrhea, especially those undergoing conventional RT.


REFERENCES

  1. Webb GJ, Brooke R, De Silva AN. Chronic radiation enteritis and malnutrition. J Dig Dis. 2013;14:350-7.

  2. Chen RC, Mamon HJ, Ancukiewicz M, et al. Dose-volume effects on patient-reported acute gastrointestinal symptoms during chemo radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;83:e513-7.

  3. Vidal-Casariego A, Calleja-Fernández A, de Urbina-González JJ, et al. Efficacy of glutamine in the prevention of acute radiation enteritis: A randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014;38:205-13.

  4. Huscher A, Bignardi M, Magri E, et al. Determinants of small bowel toxicity in postoperative pelvic irradiation for gynecological malignancies. Anticancer Res. 2009;29:4821-6.

  5. Marta GN, Silva V, de Andrade Carvalho H, et al. Intensitymodulated radiation therapy for head and neck cancer: Systematic review and meta-analysis. Radiother Oncol. 2014; 110:9-15.

  6. Schefter T, Winter K, Kwon JS, et al. RTOG 0417: Efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. Int J Radiat Oncol Biol Phys. 2014;88:101-5.

  7. Bernard S, Ouellet MP, Moffet H, Roy JS, Dumoulin C. Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: A systematic review. J Cancer Surviv. 2016;10: 351-62.

  8. Small W Jr., Mell LK, Anderson P, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008; 71:428-34.

  9. Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy - Pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11:470-9.

  10. Fuccio L, Guido A, Andreyev HJ. Management of intestinal complications in patients with pelvic radiation disease. Clin Gastroenterol Hepatol. 2012;10:1326-340000.

  11. Amzallag-Bellenger E, Oudjit A, Ruiz A, et al. Effectiveness of MR enterography for the assessment of small-bowel diseases beyond crohn disease. Radiographics 2012;32:1423-44.

  12. Chen RC, Mamon HJ, Chen YH, et al. Patient-reported acute gastrointestinal symptoms during concurrent chemo radiation treatment for rectal cancer. Cancer. 2010;116:1879-86.

  13. Jhingran A, Winter K, Portelance L, et al. A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys. 2012;84:e23-8.

  14. Chopra S, Dora T, Chinnachamy AN, et al. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: Results from a prospective study. Int J Radiat Oncol Biol Phys. 2014;88:630-5.

  15. Mohindra P, Bentzen SM, Giacomelli I, et al. Adjuvant Whole-Pelvic Radiation Therapy (WPRT) for endometrioid adenocarcinoma (EA): 45 Gy or 50/50.4 Gy? Int J Radiat Oncol Biol Phys. 2016;96:E300.

  16. Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: An independent validation study comparing peritoneal space versus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2013;85:1225-31.

  17. Samuelian JM, Callister MD, Ashman JB, et al. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;82:1981-7.

  18. Barillot I, Tavernier E, Peignaux K, et al. Impact of post-operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II rtcmiendometre french multicentre trial. Radiother Oncol. 2014;111:138-43.

  19. Shih KK, Milgrom SA, Abu-Rustum NR, et al. Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer. Gynecol Oncol. 2013;128:535-9.




2020     |     www.medigraphic.com